-+ 0.00%
-+ 0.00%
-+ 0.00%

Diagnos wins Health Canada licence for CARA retinal AI system

PUBT·07/27/2026 19:21:07
Listen to the news
Diagnos wins Health Canada licence for CARA retinal AI system
  • Diagnos received a Health Canada Class II medical device licence on July 23, 2026 to commercialize its CARA AI retinal image analysis system in Canada.
  • The clearance supports delivery to IRIS The Visual Group, enabling broader rollout to the Canadian optometry market.
  • Regulatory reviews remain ongoing with Saudi Arabia’s SFDA; an FDA submission is targeted before end-September 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Diagnos Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607271520PRIMZONEFULLFEED9798744) on July 27, 2026, and is solely responsible for the information contained therein.